Access n If you don’t have it you might as well go home. n This is the most important aspect of CRRT therapy. n Adequacy. n Filter life. n Increased blood.

Slides:



Advertisements
Similar presentations
Access for PCRRT Timothy E. Bunchman Professor Pediatrics.
Advertisements

Vascular Access The Alpha and Omega of CRRT
Regional Citrate Anticoagulation during CVVH in the
Neonatal and Infant CRRT
Central vascular Access Devices
Acute Renal Replacement Therapy for the Infant Dr.Fahad Gadi, MD Pediatrics Demonstrator King Abdulaziz University Rabigh Medical School.
MO CKD This material was prepared by Primaris, the Medicare Quality Improvement Organization for Missouri, under contract with the Centers for Medicare.
Continuous Renal Replacement Therapy. Why continuous Therapies? Continuous therapies closely mimic the GFR of native kidneys Large amounts of fluid.
Objectives of this presentation… Historical background of intraosseous (I.O.) infusion. The anatomical and physiological principle of I.O. infusion. Familiarization.
1 CRRT Therapy in the Pediatric Critical Care Patient An overview of common complications and solutions for Pediatric Critical Care Patients undergoing.
Troubleshooting Issues in CVVH Timothy L. Kudelka RN, BSN Pediatric Dialysis Program C.S. Mott Children’s Hospital University of Michigan.
Infusion Therapy.
Vn To provide and maintain daily maintenance fluid requirements. 2. To correct dehydration by supplying fluid deficit. 3. To replace essential.
Terminology and Common Issues in Pediatric CRRT John Gardner RN, BSN Nurse Manager Pediatric Nephrology & Transplant DeVos Children’s Hospital Grand Rapids.
Vascular Access for CRRT Timothy E Bunchman Professor & Director Helen DeVos Children’s Hospital Grand Rapids, MI (Thanks to Rick Hackbarth MD for his.
Vn To provide and maintain daily maintenance fluid requirements. 2. To correct dehydration by supplying fluid deficit. 3. To replace essential.
Pediatric CRRT: The Prescription
Acute Renal Replacement Therapy for the Infant Jordan M. Symons, MD University of Washington School of Medicine Children’s Hospital & Regional Medical.
ANTICOAGULATION IN CONTINUOUS RENAL REPLACEMENT THERAPY Dawn M Eding RN BSN CCRN Pediatric Critical Care Helen DeVos Children's Hospital.
What form of anticoagulation is the “best” Or why is Citrate better then Heparin or Prostacyclin.
The Prospective Pediatric CRRT (ppCRRT) Registry Stuart L. Goldstein, MD Principal Investigator and Founder Timothy E Bunchman Helen DeVos Children’s Hospital.
Current Technology for CRRT Dr. Peter Skippen, PICU. BC Children’s Hospital, Vancouver. CANADA.
HICKMAN CATHETER Thrombotic complications associated with venous access devic Thrombotic complications associated with venous access devices Occlusion.
Practical Considerations for CRRT Helen Currier RN, BSN, CNN Nancy McAfee RN, BSN, CNN.
Anticoagulation in CRRT
Access in Pediatric CRRT
Nursing Issues in Pediatric CRRT
PCRRT PRESCRIPTIONS in ARF Patrick D. Brophy MD University of Michigan Pediatric Nephrology.
Hemodialysis access: guidelines, evidence and controversies Marc R Lilien, MD, PhD Pediatric nephrologist.
By Denise Dixon. Catheter related blood stream infections (CRBSI) is a problem in our healthcare. Many clinicians and patients struggle to over come this.
Chronic Hemodialysis Catheters  In site greater than 3 weeks  Tunneled under the skin  Attached felt cuff  Indicated for acute, chronic hemodialysis,
Tomáš Zaoral1, Michal Hladík1, Jana Zapletalová2 1Pediatric intensive care unit, Department of Pediatrics,Faculty of Medicine, University Hospital Ostrava.
ECMO Extra Corporeal Membrane Oxygenation. ECMO Indications Acute, reversible lung and/or cardiac failure that is unresponsive to conventional therapies.
ECMO AT THE U of M Two era’s 1974 & patients. Kolobow Membrane Lung – Roller Pump – Adult and Peds. Patients. No Survivors 1986 to present.
Infusion Therapy.
Product Training Europe July 2002
Pediatric CRRT Programs: A tool-kit for evaluation Helen Currier BSN, RN, CNN Assistant Director, Renal/Pheresis Texas Children’s Hospital Houston, Texas.
Common Prescription Errors in Pediatric CRRT: a “Top 10 List” Jordan M. Symons, MD University of Washington School of Medicine Seattle Children’s Hospital.
Vascular Access & Cannulation
David Askenazi MD, MSPH Associate Professor of Pediatrics 2Smaller Circuits for Smaller Patients Improving Renal Support with Aquadex™ Machine.
Brophy University of Iowa Pediatric CRRT Anticoagulation Patrick Brophy MD Director Pediatric Nephrology University of Iowa- Children’s Hospital PCRRT.
Citrate Anticoagulation
Vascular Access Considerations and Options for Pediatric CRRT Stuart L. Goldstein, MD.
Complications of Pediatric CRRT Theresa A. Mottes RN Pediatric Dialysis/Research Nurse C.S. Mott Children’s Hospital University of Michigan.
GRAFT OF DIALYSIS The three most common types of access are:
Vascular Access in CRRT Timothy E Bunchman MD Professor & Director Pediatric Nephrology
Chapter 26. Dialysis PD vs HD 300,000 patients in the US on HD Destination therapy for most patients Increasing rates of DM and HTN in the US Upper extremity.
Peripheral Vascular Surgery ST 240. OBJECTIVES  Locate and identify related anatomy  Understand and explain blood pressure  Learn related terminology.
Renal Replacement Therapy in Hyperammonaemia Andrew Durward London, UK.
Intravenous cannulation
Vascular Access The Alpha and Omega of CRRT Rick Hackbarth MD Division of Pediatric Critical Care Grand Rapids, Michigan.
Columbia University Medical Center Cardiovascular Research Foundation New York City, NY Akiko Maehara, MD Use of IVUS Reduces Stent Thrombosis and Myocardial.
Alternative technique of fixing IJV catheters
Recommendations for Catheter-to-Vein Ratio
ultrasound in the dialysis unit Case studies
Access for Pediatric CRRT
George M. Foulard, William I. Douglas MD
Devices use for Neonatal AKI
Vascular Access and Infused Fluids for Pediatric CRRT
Pediatric Central Venous Catheters In Patients Less Than Two Years Of Age: Do Complication Rates Differ Between Tunneled IJ, Tunneled Femoral, and PICCs?
OUTCOMES OF REGIONAL CITRATE ANTICOAGULATION (RCA) IN PEDIARTIC CONTINUOUS RENAL REPLACEMENT THERAPY (pCRRT) IN A SINGLE CENTER Issa Alhamoud, Diane Gollhofer,
Andrew Durward St Thomas NHS Foundation Trust Orlando 2017 CRRT IN AKI.
Long-term central venous access
Access in Pediatric CRRT
Copyright © 2015 NIKKISO Co., LTD. All rights reserved.
Children’s Memorial Hospital Northwestern University
Case 20 kg child with sepsis and oliguria on norepinephrine with a BP of 95/45 Vent at 70% FIO2 and a PEEP of 8 FO at 15% K of 6 meq/dl and a BUN of 100.
CRRT dialysis circuit using regional citrate anticoagulation with the Gambro Prisma machine. CRRT dialysis circuit using regional citrate anticoagulation.
Equibments of intubation
RCA in continuous RRT: basic principles
Presentation transcript:

Access n If you don’t have it you might as well go home. n This is the most important aspect of CRRT therapy. n Adequacy. n Filter life. n Increased blood loss. n Staff satisfaction.

Vascular Access n Ideal Catheter Characteristics n Easy Insertion n Permits Adequate Blood Flow without Vessel Damage n Minimal Technical Flaws n High Recirculation Rate n Kinking n Shorter and Larger Catheters SIZE DOES MATTER n Lower Resistance n Improved Bloodflow

Vascular Access for CRRT n Match catheter size to patient size and anatomical site n One dual- or triple-lumen or two single lumen uncuffed catheters n Sites n femoral n internal jugular n avoid sub-clavian vein if possible

Pediatric CRRT Vascular Access: Performance = Blood Flow n Minimum 30 to 50 ml/min to minimize access and filter clotting n Maximum rate of 400 ml/min/1.73m 2 or n ml/kg/min in neonates and infants n 4-6 ml/kg/min in children n 2-4 ml/kg/min in adolescents

Vascular Access Two questions to be answered- n What size catheter to use? n Where to put it?

Vascular Access ppCRRT Registry Access Study n 13 Pediatric Institutions n 376 patients n 1574 circuits n Circuit survival by Catheter size, site, and modality Hackbarth R et al: IJAIO 30: , 2007

Vascular Access Hackbarth R et al: IJAIO 30: , 2007

Vascular Access Hackbarth R et al: IJAIO 30: , 2007 Shorter life span for 7 and 9 French catheters (p< 0.002) 1st 72 hrs of circuit life only

Hackbarth R et al: IJAIO 30: , 2007

Vascular Access “Location, location, location!” Femoral Vein Pros: n Accessible under almost any conditions n Easier to maintain hemostasis Cons: n Potential for kinking n More recirculation n Thrombosis n Problematic flow with increased abdominal pressures

Vascular Access “Location, location, location!” Subclavian Vein Pros: n Shorter catheter/better flow n Less recirculation Cons: n Potential for kinking n Difficult hemostasis n Potential for venous narrowing n Less accessible with cervical trauma

Vascular Access “Location, location, location!” Internal Jugular Vein Pros: n Shorter catheter/better flow n Less recirculation Cons: n Difficult hemostasis n Less accessible with cervical trauma n Catheter length problematic in small infants

Hackbarth R et al: IJAIO 30: , 2007

Vascular Access Hackbarth R et al: IJAIO 30: , 2007 Survival favors IJ Location (p< 0.05)

Vascular Access Catheter proximity n Inadvertent removal of infusions n Circuit clotting with platelet transfusions n Entraining calcium into the circuit

Vascular Access Note the relationship of the line tips.

Vascular Access for Pediatric CRRT (Hackbarth et al, CRRT 2005) n Children on CRRT/24 months n Age range 2 days – 18 yrs n Wt range Kg n Citrate anticoagulation n Avg circuit life 3.1 days ( days) n Access was size dependent

n 7 Fr dual lumen with clot in 50% n Avg BFR 27 mls/min n 8 Fr dual lumen with clot in 20% n Avg BFR 73 mls/min n 12 Fr triple lumen with no clot in any n Avg BFR 127 mls/min n This was used in in all children > 35 kg Vascular Access for Pediatric CRRT (Hackbarth et al, CRRT 2005)

Vascular Access What size catheter should we use? n Don’t use a 5 French catheter. n Choose the largest diameter that is safe for the child. n Choose the smallest catheter that will achieve the necessary flow easily. n Choose the the minimum length to position the tip for optimal flow. n In the femoral position, longer catheters will minimize recirculation

Vascular Access Where should the catheter go? n What sites are available? n Are there anatomic or physiologic constraints? n Which vessel is optimal for the catheter size? n Is the patient coagulopathic? n Consider patient mobility and risk of kinking. n Is there elevated intra-abdominal pressure?